Company Tobira Therapeutics Inc
Equities
US88883P1012
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | - |
Scott Reents
DFI | Director of Finance/CFO | 57 | - |
Corporate Secretary | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,821,231 | 18,577,505 ( 98.71 %) | 0 | 98.71 % |
Company contact information
![address Tobira Therapeutics Inc](https://cdn.zonebourse.com/static/address/17039508.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- Stock
- Company Tobira Therapeutics Inc